Susan Desmond-Hellman has been chancellor of the University of California, San Francisco, for about two years now. She moved to the university after a successful career in the pharmaceutical industry, and is determined to make the school as famous in the eyes of the public as the Mayo Clinic for innovative biomedical research, The New York Times' Denise Grady says. Grady recently spoke with Desmond-Hellman, UCSF's first female chancellor.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.